Basket | Login

 
 
 
 

Clinical trials by condition

Phase III trials

At risk of developing Alzheimer’s dementia

Currently no clinical trials in this category

Prodromal / Mild Cognitive Impairment due to Alzheimer’s disease

  1. ANAVEX®2-73-AD-004
  2. EMBARK
  3. NorAD

Mild Alzheimer's dementia

  1. NorAD

Moderate Alzheimer's dementia

  1. NorAD

Severe Alzheimer's dementia

Currently no clinical trials in this category

Agitation in Alzheimer's dementia

  1. 17-AVP-786-305

People with dementia-related psychosis

Currently no clinical trials in this category

Subjective memory complaints or family history of Alzheimer's disease

  1. LO-MAPT

Frontotemporal dementia

  1. INFRONT-3

 

 
 

Last Updated: Wednesday 21 April 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options